lobbying_activities: 3016673

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3016673	b08a2c9b-db28-4017-a78a-1c38f69df106	Q2	MEHLMAN CONSULTING, INC.	284950	WEDGEWOOD PHARMACY LLC	2023	second_quarter	ANI	Issues related to animal drug compounding.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2023-07-19T14:43:05-04:00